Dr. Dino PratoEnvita Medical Centers · Founder and CEO at Envita Medical Centers

What Happens When Breast Cancer Comes Back — and How We Stopped It

15 Oct 2025 · 1 min

Watch on YouTube

0:36

In this presentation, the speaker recounts a clinical case where a patient, previously declared cancer‑free after a mastectomy and lumpectomy, experienced a recurrence in the opposite breast within a year. The initial management followed standard NCCN guidelines, employing high‑dose chemotherapy and an integrative assay called Sinatra Dx to monitor status. The speaker attributes the relapse to improper testing and treatment planning. To reverse the disease, the team performed comprehensive, targeted molecular and immune profiling, identified actionable pathways, and administered an immune‑focused therapy regimen that halted tumor growth with minimal side effects, leading to a favorable clinical response.

Chapters

Imagine being told you beat breast cancer only to find out a year later it's back. Not just back, but it's in the other breast. That's after a mastectomy and a lumpectomy. That playbook involves high dose chemotherapy, which was the standard NCCNN guidelines, and even an integrative test called the Sinatra dx, which the patient ran to see if they were doing well. A year later, the disease returns. This is what happens with improper testing and treatment planning. What we did to turn around is we ran the right testing, targeted the immune, shut down the cancer with minimal to little side effects, helping the patient respond.